Hermes Biosciences is a life-science tools company building a benchtop, hands-off system that automates the isolation of extracellular vesicles (EVs), enabling standardized, high-yield workflows for clinical and translational researchers.

Its platform is designed for academia, pharma, and clinical labs that need reproducible EV prep at scale, helping unlock cell-to-cell “molecular conversations” for diagnostics, biomarker discovery, and drug development.

Exponential Molecular’s technology allows researchers to create archival copies of precious biosamples. This allows the same samples to be studied with a variety of different assays without destruction of the original, exponentially increasing the value of each sample.

Aralez Bio is a biotechnology company that uses a proprietary enzyme engineering platform to manufacture noncanonical amino acids – key building blocks for next‑generation peptide and protein therapeutics – more efficiently, cleanly, and at scale for pharmaceutical and biotech partners.

By replacing traditional, resource‑intensive chemical synthesis with biocatalysis, Aralez Bio offers a cheaper, greener, and faster route to a broad portfolio of novel amino acid analogues, expanding medicinal chemistry “chemical space” while improving the sustainability and resilience of drug discovery and manufacturing supply chains.

Partillion Bio was spun out of Professor Dino Di Carlo’s lab at UCLA. The company has developed an award-winning, patent protected unique reagent kit that incorporates biotinylated nanovials, which are compatible with common droplet generators, enabling for the first time the ability to interrogate difficult cell types, e.g., adherent cells like many types of immune cells which will not activate their immune response in the absence of certain mechanical stimulus, that is not possible with conventional emulsions.